alpha-aminopyridine has been researched along with Memory Disorders in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Akhtar, M; Hasan, N; Najmi, AK; Parvez, S; Zameer, S | 1 |
| Bolsius, YG; Havekes, R; Heckman, PRA; Meerlo, P; Prickaerts, J; Raven, F; Roig Kuhn, F | 1 |
| Chen, W; Fu, HR; Gao, YF; Wang, H; Wang, L; Wang, XD; Xu, XY; Xu, Y; Zhang, FF; Zhang, HT; Zhang, JG | 1 |
| Akhtar, M; Hasan, N; Najmi, AK; Parvez, S; Yar, MS; Zameer, S | 1 |
| Milani, H; Prickaerts, J; Santiago, A; Schepers, M; Soares, LM; Vanmierlo, T; Weffort de Oliveira, RM | 1 |
| Guo, L; Huang, P; Li, C; Lu, Q; Xu, X; Zhou, M | 1 |
| Farde, L; Forsberg, A; Halldin, C; Mattsson, P; Nilsson, LG; Nyberg, L; Persson, J | 1 |
| Feng, X; Gupta, N; Jopson, TD; Liu, S; Paladini, MS; Rosi, S; West, BL | 1 |
| Akahane, A; Aoki, S; Iwashita, A; Matsuda, R; Matsuoka, N; Mihara, K; Mihara, T; Mitani, Y; Yamamoto, H; Yarimizu, J | 1 |
9 other study(ies) available for alpha-aminopyridine and Memory Disorders
| Article | Year |
|---|---|
Roflumilast Reduces Pathological Symptoms of Sporadic Alzheimer's Disease in Rats Produced by Intracerebroventricular Streptozotocin by Inhibiting NF-κB/BACE-1 Mediated Aβ Production in the Hippocampus and Activating the cAMP/BDNF Signalling Pathway.
Topics: Alzheimer Disease; Aminopyridines; Animals; Benzamides; Brain-Derived Neurotrophic Factor; Cyclopropanes; Disease Models, Animal; Glycogen Synthase Kinase 3 beta; Hippocampus; Maze Learning; Memory Disorders; NF-kappa B; Rats; Streptozocin | 2022 |
Phosphodiesterase inhibitors roflumilast and vardenafil prevent sleep deprivation-induced deficits in spatial pattern separation.
Topics: Aminopyridines; Animals; Benzamides; Cyclopropanes; Hippocampus; Male; Memory Disorders; Mice; Phosphodiesterase 4 Inhibitors; Sleep Deprivation; Spatial Memory; Vardenafil Dihydrochloride | 2020 |
The Phosphodiesterase-4 Inhibitor Roflumilast, a Potential Treatment for the Comorbidity of Memory Loss and Depression in Alzheimer's Disease: A Preclinical Study in APP/PS1 Transgenic Mice.
Topics: Alzheimer Disease; Aminopyridines; Amyloid beta-Protein Precursor; Animals; Behavior, Animal; Benzamides; Cerebral Cortex; Cyclopropanes; Depression; Disease Models, Animal; Hippocampus; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phosphodiesterase 4 Inhibitors; Presenilin-1; Recognition, Psychology | 2020 |
Roflumilast and tadalafil improve learning and memory deficits in intracerebroventricular Aβ1-42 rat model of Alzheimer's disease through modulations of hippocampal cAMP/cGMP/BDNF signaling pathway.
Topics: Alzheimer Disease; Aminopyridines; Amyloid beta-Peptides; Animals; Benzamides; Brain-Derived Neurotrophic Factor; Cyclic AMP; Cyclic GMP; Cyclopropanes; Cytokines; Gene Expression Regulation; Hippocampus; Male; Memory Disorders; Morris Water Maze Test; Oxidative Stress; Peptide Fragments; Random Allocation; Rats; Rats, Wistar; Tadalafil; Vasodilator Agents | 2021 |
Roflumilast promotes memory recovery and attenuates white matter injury in aged rats subjected to chronic cerebral hypoperfusion.
Topics: Aging; Aminopyridines; Animals; Arginase; Benzamides; Brain Ischemia; Chronic Disease; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Hippocampus; Male; Maze Learning; Memory Disorders; Microglia; Neurodegenerative Diseases; Neuroprotective Agents; Nootropic Agents; Optic Tract; Random Allocation; Rats, Wistar; White Matter | 2018 |
KCNQ/Kv7 channel activator flupirtine protects against acute stress-induced impairments of spatial memory retrieval and hippocampal LTP in rats.
Topics: Aminopyridines; Animals; Anthracenes; Carbamates; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Long-Term Potentiation; Male; Maze Learning; Memory Disorders; Nootropic Agents; Phenylenediamines; Phosphorylation; Potassium Channel Blockers; Rats, Sprague-Dawley; Spatial Memory; Stress, Psychological | 2014 |
β-Amyloid binding in elderly subjects with declining or stable episodic memory function measured with PET and [¹¹C]AZD2184.
Topics: Aged; Aminopyridines; Amyloid beta-Peptides; Benzothiazoles; Carbon Radioisotopes; Cognition Disorders; Female; Humans; Male; Memory Disorders; Memory, Episodic; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Colony-stimulating factor 1 receptor blockade prevents fractionated whole-brain irradiation-induced memory deficits.
Topics: Aminopyridines; Animals; Brain; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pyrroles; Radiation Effects; Receptor, Macrophage Colony-Stimulating Factor | 2016 |
Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Aminopyridines; Animals; CHO Cells; Cognition Disorders; Cricetinae; Cricetulus; Dopamine; Haloperidol; Humans; Male; Memory Disorders; Mice; Mice, Inbred C57BL; MPTP Poisoning; Phenethylamines; Piperazines; Rats; Rats, Inbred F344; Rats, Wistar; Receptor, Adenosine A1; Receptor, Adenosine A2A; Scopolamine | 2007 |